Indications
Alleviation of inflammation and pain in both acute and chronic musculoskeletal disorders.
Composition
- Active substance
- meloxicam
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Meloxivet
- Active substance
- meloxicam
- Group
- Veterinary medicines
- Marketing authorisation holder
- Eli Lilly and Company Limited
- Status
- Withdrawn
- EU authorisation
- 14 Nov 2007
- EMA product number
- EMEA/V/C/000124